Nasdaq: TNGX

Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker TNGX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
TNGX
Exchange
Nasdaq
SEC CIK
1819133
Official filings
SEC EDGAR

Research TNGX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Tango Therapeutics, Inc.'s stock ticker?

Tango Therapeutics, Inc. trades under the ticker symbol TNGX on Nasdaq. Its SEC Central Index Key (CIK) is 1819133.

Where can I read Tango Therapeutics, Inc.'s SEC filings?

The TNGX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Tango Therapeutics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze TNGX's financial statements?

The TNGX Financials page shows Tango Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does TNGX compare with its peers and the market?

The TNGX Peer Comparison page lines Tango Therapeutics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.